KEGG   DRUG: Gefurulimab
Entry
D12208                      Drug                                   
Name
Gefurulimab (USAN)
Formula
C1230H1878N356O391S8
Exact mass
28147.5779
Mol weight
28164.7429
Sequence
EVQLVESGGG LVKPGGSLRL SCAASGRPVS NYAAAWFRQA PGKEREFVSA INWQKTATYA
DSVKGRFTIS RDNAKNSLYL QMNSLRAEDT AVYYCAAVFR VVAPKTQYDY DYWGQGTLVT
VSSGGGGAGG GGAGGGGSEV QLVESGGGLV QPGGSLRLSC AASGRAHSDY AMAWFRQAPG
QEREFVAGIG WSGGDTLYAD SVRGRFTNSR DNSKNTLYLQ MNSLRAEDTA VYYCAARQGQ
YIYSSMRSDS YDYWGQGTLV TVSS
(Disulfide bridge: 22-95, 160-234)
  Type
Peptide
Efficacy
Anti-complement C5 antibody
Comment
Monoclonal antibody
Treatment of diseases caused by complement activation
Target
C5 [HSA:727] [KO:K03994]
  Pathway
hsa04610  Complement and coagulation cascades
Brite
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Organismal systems
   Complement and coagulation
    C5
     D12208  Gefurulimab (USAN)
Other DBs
CAS: 2456407-94-4
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system